STEVEN JACOBS: Open Payments
NPI 1750455259 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,255 in 55 payments from 18 companies in 2025. Trend: 2023 $1,435 · 2024 $979 · 2025 $1,255
Food & beverage: $1,255
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $273 |
| GlaxoSmithKline, LLC. | 9 | $167 |
| AstraZeneca Pharmaceuticals LP | 5 | $118 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| PFIZER INC. | 5 | $112 |
| Viatris Specialty LLC | 3 | $80 |
| JAZZ PHARMACEUTICALS INC. | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Electromed, Inc. | 2 | $41 |
| United Therapeutics Corporation | 1 | $34 |
Products named: TEZSPIRE, TRELEGY ELLIPTA, LEQVIO, YUPELRI, OTEZLA, PREVNAR 20, XYWAV, OFEV.
Industry payments across CA — which companies pay providers there.
